|
Name |
Benzeneethanol, 4-(acetyloxy)-
|
| Molecular Formula | C10H12O3 | |
| IUPAC Name* |
[4-(2-hydroxyethyl)phenyl] acetate
|
|
| SMILES |
CC(=O)OC1=CC=C(C=C1)CCO
|
|
| InChI |
InChI=1S/C10H12O3/c1-8(12)13-10-4-2-9(3-5-10)6-7-11/h2-5,11H,6-7H2,1H3
|
|
| InChIKey |
ZTXTZJHRRIQLRH-UHFFFAOYSA-N
|
|
| Synonyms |
Benzeneethanol, 4-(acetyloxy)-; 60037-43-6; [4-(2-hydroxyethyl)phenyl] acetate; 4-(2-Hydroxyethyl)phenyl acetate; 4-Acetoxybenzeneethanol; 2-(4-methylcarbonyloxyphenyl)-1-ethanol; 2-p-acetoxyphenylethanol; 4-Acetoxyphenethyl alcohol; SCHEMBL6662199; 4-(2-Hydroxyethyl)phenylacetate; DTXSID70343012; 4-(2-Hydroxyethyl)phenyl acetate #
|
|
| CAS | 60037-43-6 | |
| PubChem CID | 586676 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 180.2 | ALogp: | 1.3 |
| HBD: | 1 | HBA: | 3 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 46.5 | Aromatic Rings: | 1 |
| Heavy Atoms: | 13 | QED Weighted: | 0.567 |
| Caco-2 Permeability: | -4.268 | MDCK Permeability: | 0.00003200 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.046 |
| 30% Bioavailability (F30%): | 0.954 |
| Blood-Brain-Barrier Penetration (BBB): | 0.982 | Plasma Protein Binding (PPB): | 47.54% |
| Volume Distribution (VD): | 0.619 | Fu: | 62.56% |
| CYP1A2-inhibitor: | 0.549 | CYP1A2-substrate: | 0.112 |
| CYP2C19-inhibitor: | 0.317 | CYP2C19-substrate: | 0.23 |
| CYP2C9-inhibitor: | 0.091 | CYP2C9-substrate: | 0.729 |
| CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.444 |
| CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.314 |
| Clearance (CL): | 6.226 | Half-life (T1/2): | 0.836 |
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.033 |
| Drug-inuced Liver Injury (DILI): | 0.147 | AMES Toxicity: | 0.047 |
| Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.254 |
| Skin Sensitization: | 0.9 | Carcinogencity: | 0.874 |
| Eye Corrosion: | 0.203 | Eye Irritation: | 0.984 |
| Respiratory Toxicity: | 0.035 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001422 | ![]() |
0.532 | D02HXS | ![]() |
0.421 | ||
| ENC005495 | ![]() |
0.531 | D03XTC | ![]() |
0.382 | ||
| ENC000350 | ![]() |
0.524 | D05CKR | ![]() |
0.377 | ||
| ENC000223 | ![]() |
0.488 | D01UXC | ![]() |
0.375 | ||
| ENC000870 | ![]() |
0.469 | D02AQY | ![]() |
0.370 | ||
| ENC005828 | ![]() |
0.456 | D0B3QM | ![]() |
0.352 | ||
| ENC005827 | ![]() |
0.456 | D0I2MK | ![]() |
0.348 | ||
| ENC002242 | ![]() |
0.440 | D0GY5Z | ![]() |
0.340 | ||
| ENC005811 | ![]() |
0.426 | D01CRB | ![]() |
0.340 | ||
| ENC005812 | ![]() |
0.426 | D0VB0U | ![]() |
0.333 | ||